US Patent 11547727 Chimeric antigen receptor-modified NK-92 cells
Patent 11547727 was granted and assigned to ImmunityBio on January, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11547727 Chimeric antigen receptor-modified NK-92 cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
